Literature DB >> 15507643

Generation of synthetic severe acute respiratory syndrome coronavirus pseudoparticles: implications for assembly and vaccine production.

Yue Huang1, Zhi-yong Yang, Wing-pui Kong, Gary J Nabel.   

Abstract

The recently emerged severe acute respiratory syndrome coronavirus (SARS-CoV) contains four structural genes, two replicase-transcriptase open reading frames, and more than five potential genes of unknown function. Despite this relative simplicity, the molecular regulation of SARS-CoV replication and assembly is not understood. Here, we report that two viral genes, encoding the SARS-CoV membrane (M) and nucleocapsid (N) proteins, are necessary and sufficient for formation of virus-like particles. Expression vectors encoding these two proteins were synthesized by using preferred human codons. When M and N expression plasmids were cotransfected into human 293 renal epithelial cells, pseudoparticles formed readily. The addition of a third gene, encoding the spike (S) glycoprotein, facilitated budding of particles that contained a corona-like halo resembling SARS-CoV when examined by transmission electron microscopy, with a buoyant density characteristic of coronaviruses. Specific biochemical interactions of these proteins were also shown in vitro. The S, M, and N proteins of the SARS-CoV are, therefore, necessary and sufficient for pseudovirus assembly. These findings advance the understanding of the morphogenesis of SARS-CoV and enable the generation of safe, conformational mimetics of the SARS virus that may facilitate the development of vaccines and antiviral drugs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15507643      PMCID: PMC525052          DOI: 10.1128/JVI.78.22.12557-12565.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  The membrane M protein carboxy terminus binds to transmissible gastroenteritis coronavirus core and contributes to core stability.

Authors:  D Escors; J Ortego; H Laude; L Enjuanes
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

2.  p53 inhibition by the LANA protein of KSHV protects against cell death.

Authors:  J Friborg; W Kong; M O Hottiger; G J Nabel
Journal:  Nature       Date:  1999 Dec 23-30       Impact factor: 49.962

3.  Modifications of the human immunodeficiency virus envelope glycoprotein enhance immunogenicity for genetic immunization.

Authors:  Bimal K Chakrabarti; Wing-pui Kong; Bei-yue Wu; Zhi-Yong Yang; Jacques Friborg; Xu Ling; Steven R King; David C Montefiori; Gary J Nabel
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

4.  Characterization of the coronavirus M protein and nucleocapsid interaction in infected cells.

Authors:  K Narayanan; A Maeda; J Maeda; S Makino
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

5.  Identification of a novel coronavirus in patients with severe acute respiratory syndrome.

Authors:  Christian Drosten; Stephan Günther; Wolfgang Preiser; Sylvie van der Werf; Hans-Reinhard Brodt; Stephan Becker; Holger Rabenau; Marcus Panning; Larissa Kolesnikova; Ron A M Fouchier; Annemarie Berger; Ana-Maria Burguière; Jindrich Cinatl; Markus Eickmann; Nicolas Escriou; Klaus Grywna; Stefanie Kramme; Jean-Claude Manuguerra; Stefanie Müller; Volker Rickerts; Martin Stürmer; Simon Vieth; Hans-Dieter Klenk; Albert D M E Osterhaus; Herbert Schmitz; Hans Wilhelm Doerr
Journal:  N Engl J Med       Date:  2003-04-10       Impact factor: 91.245

6.  Identification of severe acute respiratory syndrome in Canada.

Authors:  Susan M Poutanen; Donald E Low; Bonnie Henry; Sandy Finkelstein; David Rose; Karen Green; Raymond Tellier; Ryan Draker; Dena Adachi; Melissa Ayers; Adrienne K Chan; Danuta M Skowronski; Irving Salit; Andrew E Simor; Arthur S Slutsky; Patrick W Doyle; Mel Krajden; Martin Petric; Robert C Brunham; Allison J McGeer
Journal:  N Engl J Med       Date:  2003-03-31       Impact factor: 91.245

7.  Human immunodeficiency virus type 1-specific immunity after genetic immunization is enhanced by modification of Gag and Pol expression.

Authors:  Y Huang; W P Kong ; G J Nabel
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

8.  Infectious bronchitis virus E protein is targeted to the Golgi complex and directs release of virus-like particles.

Authors:  E Corse; C E Machamer
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

9.  Genetic evidence for a structural interaction between the carboxy termini of the membrane and nucleocapsid proteins of mouse hepatitis virus.

Authors:  Lili Kuo; Paul S Masters
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

10.  The assembly of Ebola virus nucleocapsid requires virion-associated proteins 35 and 24 and posttranslational modification of nucleoprotein.

Authors:  Yue Huang; Ling Xu; Yongnian Sun; Gary J Nabel
Journal:  Mol Cell       Date:  2002-08       Impact factor: 17.970

View more
  78 in total

1.  Severe acute respiratory syndrome coronavirus 3a protein is released in membranous structures from 3a protein-expressing cells and infected cells.

Authors:  Cheng Huang; Krishna Narayanan; Naoto Ito; C J Peters; Shinji Makino
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

Review 2.  The molecular biology of coronaviruses.

Authors:  Paul S Masters
Journal:  Adv Virus Res       Date:  2006       Impact factor: 9.937

3.  Severe acute respiratory syndrome coronavirus 7a accessory protein is a viral structural protein.

Authors:  Cheng Huang; Naoto Ito; Chien-Te K Tseng; Shinji Makino
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

4.  Epithelial cells lining salivary gland ducts are early target cells of severe acute respiratory syndrome coronavirus infection in the upper respiratory tracts of rhesus macaques.

Authors:  Li Liu; Qiang Wei; Xavier Alvarez; Haibo Wang; Yanhua Du; Hua Zhu; Hong Jiang; Jingying Zhou; Pokman Lam; Linqi Zhang; Andrew Lackner; Chuan Qin; Zhiwei Chen
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

5.  A single tyrosine in the severe acute respiratory syndrome coronavirus membrane protein cytoplasmic tail is important for efficient interaction with spike protein.

Authors:  Corrin E McBride; Carolyn E Machamer
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

6.  The ORF7b protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is expressed in virus-infected cells and incorporated into SARS-CoV particles.

Authors:  Scott R Schaecher; Jason M Mackenzie; Andrew Pekosz
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

7.  Self-assembly of severe acute respiratory syndrome coronavirus membrane protein.

Authors:  Ying-Tzu Tseng; Shiu-Mei Wang; Kuo-Jung Huang; Amber I-Ru Lee; Chien-Cheng Chiang; Chin-Tien Wang
Journal:  J Biol Chem       Date:  2010-02-12       Impact factor: 5.157

8.  Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease.

Authors:  Luis Enjuanes; Marta L Dediego; Enrique Alvarez; Damon Deming; Tim Sheahan; Ralph Baric
Journal:  Virus Res       Date:  2007-04-09       Impact factor: 3.303

9.  Studies on membrane topology, N-glycosylation and functionality of SARS-CoV membrane protein.

Authors:  Daniel Voss; Susanne Pfefferle; Christian Drosten; Lea Stevermann; Elisabetta Traggiai; Antonio Lanzavecchia; Stephan Becker
Journal:  Virol J       Date:  2009-06-18       Impact factor: 4.099

Review 10.  SARS coronavirus accessory proteins.

Authors:  Krishna Narayanan; Cheng Huang; Shinji Makino
Journal:  Virus Res       Date:  2007-11-28       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.